DSpace Repository

Synthesis, characterization and bioactivities of dative donor ligand N-heterocyclic carbene (NHC) precursors and their Ag(I)NHC coordination compounds

Show simple item record

dc.contributor.author Kazancı, A.
dc.contributor.author Gök, Y.
dc.contributor.author Kaya, R.
dc.contributor.author Aktaş, A.
dc.contributor.author Taslimi, P.
dc.contributor.author Gülçin, İ.
dc.date.accessioned 2022-10-06T12:50:46Z
dc.date.available 2022-10-06T12:50:46Z
dc.date.issued 2021
dc.identifier.issn 02775387 (ISSN)
dc.identifier.uri http://hdl.handle.net/11616/71923
dc.description.abstract This study contains the synthesis of N-phthalimidomethyl-substituted NHC precursors and their Ag(I)NHC coordination compounds. The NHC precursors were synthesized from the 1-(N-phthalimidomethyl)benzimidazole and alkyl/aryl halide. The Ag(I)NHC coordination compounds were synthesized from the N-phthalimidomethyl substituted benzimidazolium salts and silver oxide via the in-situ deprotonation method. The formation of all compounds was proved fully by 1H NMR, 13C NMR, FTIR and elemental analysis techniques. Also, these novel N-phthalimidomethyl substituted NHC precursors and Ag(I)NHC coordination compounds were found as effective inhibitors for acetylcholinesterase (AChE), human carbonic anhydrase I isoenzyme (hCA I), human carbonic anhydrase II isoenzyme (hCA II), and butyrylcholinesterase (BChE) with inhibition constants (Kis) in the range of 1.00 ± 0.14–2.31 ± 0.58 µM for hCA I, 1.30 ± 0.21–2.85 ± 0.56 µM for hCA II, 0.35 ± 0.06–2.58 ± 0.70 µM for AChE, and 0.42 ± 0.01–1.27 ± 0.16 µM for BChE, respectively. © 2020 Elsevier Ltd
dc.source Polyhedron
dc.title Synthesis, characterization and bioactivities of dative donor ligand N-heterocyclic carbene (NHC) precursors and their Ag(I)NHC coordination compounds


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record